On the relationship between viral infection and autoimmunity

Journal of Autoimmunity

Volumn 16, Issue 3, 2001, Pages 341-345

  Panoutsakopoulou, Vily ^a   Cantor, Harvey ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN PRESENTATION; AUTOIMMUNITY; CONFERENCE PAPER; CROSS REACTION; DISEASE ASSOCIATION; IMMUNE RESPONSE; MEMORY CELL; MOLECULAR MIMICRY; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; VIRUS INFECTION;

EID: 0034984268     PISSN: 08968411     EISSN: None     Source Type: Journal    
DOI: 10.1006/jaut.2000.0480     Document Type: Conference Paper

References (63)

1. Coxsackie B virus and diabetes
2. Relation of antecedent illness to development of diabetes in children
3. Studies on autoimmunity for T-cell-mediated beta cell destruction
4. Clinical viral infections and multiple sclerosis
5. Theiler's murine encephalomyelitis: A model of demyelination and persistence of virus
6. Experimental models of virus-induced demyelination of the central nervous system
7. Class II-restricted T cell responses in Theiler's murine encephalomyelitis virus (TMEV)-induced demyelinating disease. III. Failure of neuroantigen-specific immune tolerance to affect the clinical course of demyelination
8. Immunity causing blindness: Five different paths to herpes stromal keratitis
9. Molecular mimicry by herpes simplex virus-1: Autoimmune disease after viral infection
10. T-cell receptor crossreactivity and autoimmune disease
11. Chlamydia infections and heart disease linked through antigenic mimicry
12. Persistent infection with Theiler's virus leads to CNS autoimmunity via epitope spreading
13. Coxsackie virus-induced diabetes: Initiation by bystander damage and not molecular mimicry
14. Insulin-dependent diabetes mellitus induced in transgenic mice by ectopic expression of class II MHC and interferon-gamma
15. Genetic absence of gamma-interferon delays but does not prevent diabetes in NOD mice
16. Interferon-y impacts at multiple points during the progressive autoimmune diabetes
17. Local expression of TNF Alpha in neonatal NOD mice promotes diabetes by enhancing presentation of islet antigens
18. Local expression of transgene encoded TNF alpha in islets prevents autoimmune diabetes in nonobese diabetic (NOD) mice by preventing the development of auto-reactive islet-specific T cells
19. Pancreatic expression of interleukin-4 abrogates insulitis and autoimmune diabetes in nonobese diabetic (NOD) mice
20. Interleukin-4 deficiency does not exacerbate disease in NOD mice
21. Primary demyelination in transgenic mice expressing interferon-y
22. Astrocyte-specific but not neuron-specific transmembrane TNF triggers inflammation and degeneration in the central nervous system of transgenic mice
23. Herpetic stromal keratitis in the reconstituted scid mouse model
24. Resistance to herpes stromal keratitis conferred by an IgG2a-derived peptide
25. Eta-1 (osteopontin): An early component of Type 1 (cell-mediated) immunity
26. Homing to central nervous system vasculature by antigen-specific lymphocytes. II. Lymphocyte/endothelial cell adhesion during the initial stages of autoimmune demyelination
27. Adhesion-related molecules in the CNS. Upregulation correlates with inflammatory cell influx during relapsing EAE
28. Evidence for involvement of ICAM-1 and VCAM-1 in lymphocyte interaction with endothelium in experimental autoimmune encephalomyelitis in the central nervous system in the SJL/J mouse
29. Expression of vascular addressins and ICAM-1 by endothelial cells in the spinal cord during chronic relapsing experimental allergic encephalomyelitis in the Biozzi AB/H mouse
30. Interaction of T lymphocytes with cerebral endothelial cells in vitro
31. Inflammatory leukocytes and cytokines in the peptide-induced disease of experimental allergic encephalomyelitis in SJL and B10.PL mice
32. Cytokine production by cells in cerebrospinal fluid during experimental allergic encephalomyelitis in SJL/J mice
33. An important role for the chemokine macrophage inflammatory protein-1 alpha in the pathogenesis of the T cell-mediated autoimmune disease, experimental autoimmune encephalomyelitis
34. Tolerance and autoimmunity in TCR transgenic mice specific for myelin basic protein
35. Peptide-induced T cell receptor down-regulation on naive T cells predicts agonist/partial agonist properties and strictly correlates with T cell activation
36. The role of lymphocyte subsets in accelerated diabetes in nonobese diabetic-rat insulin promoter-B7-1 (NOD-RIP-B7-1) mice
37. The response of Langerhans cells in the cornea to herpetic keratitis
38. Immunobiology of Langerhans cells on the surface: II. Role of central corneal Langerhans cells in stromal keratitis following experimental HSV-1 infection in mice
39. T cell responses induced by the parenteral injection of antigen-modified syngeneic cells. I. Induction, characterization, and regulation of antigen-specific T helper cells involved in delayed-type hypersensitivity responses
40. An analysis of the subpopulations in draining lymph node cells and MHC antigen induction in murine hepatic keratitis
41. Evolution of the T-cell repertoire during the course of experimental immune-mediated demyelinating disease
42. Epitope spreading
43. The functional significance of epitope spreading and its regulation by co-stimulatory molecules
44. Class II-restricted T cell responses in Theiler's murine encephalomyelitis virus (TMEV)-induced demyelinating disease. I. Cross-specificity among TMEV substrains and related picornaviruses, but not myelin proteins
45. Class II-restricted T cell responses in Theiler's murine encephalomyelitis virus-induced demyelinating disease. VI. Potentiation of demyelination with and characterization of an immunopathologic CD4+ T cell line specific for an immunodominant Vp2 epitope
46. Flow cytometric and functional analyses of central nervous system-infiltrating cells in SJL/J mice with Theiler's virus-induced demyelinating disease. Evidence for a CD4+ T cell-mediated pathology
47. Differential expression of inflammatory cytokines parallels progression of CNS pathology in two clinically distinct models of multiple sclerosis
48. Virus infection triggers insulin-dependent diabetes mellitus in a transgenic model: Role of anti-self (virus) immune response
49. Ablation of "tolerance" and induction of diabetes by virus infection in viral antigen transgenic mice
50. Molecular mimicry in T cell-mediated autoimmunity: Viral peptides activate human T cell clones specific for myelin basic protein (MBP)
51. Identification of high potency microbial and self ligands for a human autoreactive class II-restricted T cell clone
52. Immunogenetic influence of IgH-1 phenotype on experimental herpes simplex virus type-1 corneal infection
53. The influence of Igh-C linked loci on murine herpes keratitis
54. Clinical, pathologic and immunopathologic characteristics of experimental murine herpes simplex virus stromal keratitis and uveitis is controlled by gene products from the Igh-1 locus on chromosome 12
55. Histology and immunohistology of Igh-1-restricted herpes simplex keratitis in BALB/c congenic mice
56. Molecular mimicry and autoimmunity
57. Identification of LFA-1 as a candidate autoantigen in treatment-resistant Lyme arthritis
58. Viruses, host responses, and autoimmunity
59. Transgenic mice that express a myelin basic protein-specific T cell receptor develop spontaneous autoimmunity
60. Acute EAE in mice. I. Adjuvant action of Bordetella pertussis is due to vasoactive amine sensitization and increased vascular permeability of the CNS
61. Elicitation of experimental allergic encephalomyelitis (EAE) in mice with the aid of pertussigen
62. Virus-induced immunoinflammatory lesions in the absence of viral antigen recognition
63. Bystander activation of CD4+ T cells accounts for herpetic ocular lesions